Back to GOLDMAN SACHS GROUP INC GOLDMAN SACHS GROUP INC

CAPRCAPR
7 quarters

Position history for GOLDMAN SACHS GROUP INCGOLDMAN SACHS GROUP INC's holdings in CAPRICOR THERAPEUTICS INC

GOLDMAN SACHS GROUP INC holds 1.6M shares of CAPR (CAPRICOR THERAPEUTICS INC), worth $38M as of 2026-Q2. The position was increased (+73.0% shares). CAPR represents 0.0% of GOLDMAN SACHS GROUP INC's portfolio.

Current Value

$38M

Current Shares

1.6M

Total Value Change

+$33.9M

Total Shares Change

+1.3M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
1.6M
+73.0%
$38M0.0%$24.08
44
2026-Q1
Increased
911,976
+103.6%
$27.7M0.0%$25.84
46
2025-Q4
Increased
447,983
+155.1%
$12.9M0.0%$28.96
45
2025-Q3
Increased
175,642
+144.1%
$1.3M0.0%$7.41
41
2025-Q2
Decreased
71,971
-82.5%
$714,6720.0%$11.15
0
2025-Q1
Increased
411,141
+39.5%
$3.9M0.0%$11.50
35
2024-Q4
New
294,768
-
$4.1M0.0%$13.76
37

Other major holders of CAPR: BlackRock, Inc., STATE STREET CORP, VANGUARD GROUP INC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used